Європейський Союз - литовська - EMA (European Medicines Agency)

janssen-cilag international nv - darunaviras - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

Європейський Союз - литовська - EMA (European Medicines Agency)

merck sharp & dohme b.v. - efavirenzas - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - stocrin yra nurodytas kartu su priešvirusiniais vaistais nuo žmogaus imunodeficito viruso-1 (Živ-1) infekuotų suaugusių, paauglių ir trejų metų amžiaus vaikų. stocrin nebuvo tinkamai tirti pacientai, sergantys progresavusia Živ liga, t. y. pacientams, kurių cd4 skaičius < 50 ląstelių/mm3, ar po nesėkmės proteazė-inhibitorius (pi)-kurių sudėtyje režimų. nors kryžminis atsparumas efavirenz su pis nebuvo patvirtinti, yra šiuo metu nepakanka duomenų apie veiksmingumo vėliau naudoti pi pagrįstos terapijos derinys, kai sugenda režimų, kurių sudėtyje yra stocrin.

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

richard bittner ag - paracetamolis/kofeinas/fenilefrino hidrochloridas/terpinhidratas/askorbo rūgštis - tabletės - 500 mg/25 mg/5 mg/20 mg/30 mg - paracetamol, combinations excl. psycholeptics

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

richard bittner ag - paracetamolis/fenilefrino hidrochloridas/askorbo rūgštis - milteliai geriamajam tirpalui - 600 mg/10 mg/40 mg; 1000 mg/10 mg/40 mg; 750 mg/10 mg/60 mg; 1000 mg/10 mg/70 mg - paracetamol, combinations excl. psycholeptics

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

krka, d.d., novo mesto - montelukastas - plėvele dengtos tabletės - 10 mg; 5 mg; 4 mg - montelukast

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

richard bittner ag - paracetamolis/fenilefrino hidrochloridas/askorbo rūgštis - milteliai geriamajam tirpalui paketėlyje - 300 mg/5 mg/20 mg - paracetamol, combinations excl. psycholeptics

Європейський Союз - литовська - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Європейський Союз - литовська - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 ir 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 ir 5.

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

accord healthcare b.v. - propafenono hidrochloridas - plėvele dengtos tabletės - 300 mg; 150 mg - propafenone

Литва - литовська - SMCA (Valstybinė vaistų kontrolės tarnyba)

viatris sia - propafenono hidrochloridas - plėvele dengtos tabletės - 300 mg; 150 mg - propafenone